Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
When it comes to finding a job, the interview may cause the most anxiety for applicants. Cheddar News' docuseries, Ready 4 Work, speaks with job seekers who learn what to do when that all-important interview is remote.
Major averages rose in Wednesday's opening session but the Nasdaq fell after Alphabet reported cloud revenue below Wall Street estimates, despite topping profit views.
An off-duty commercial pilot riding in an extra cockpit seat on a Horizon Air flight said “I’m not OK” just before trying to cut the engines midflight and later told police he had recently taken psychedelic mushrooms as his mental health worsened, according to a federal complaint made public Tuesday.
California regulators have revoked the license of a robotaxi service owned by General Motors after determining its driverless cars that recently began transporting passengers throughout San Francisco are a dangerous menace.
